Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2003
03/27/2003US20030061633 Nucleotide sequences coding dihydrodipicolinate synthase for use in generation of amino acids for use in animal feeds and nutrients
03/27/2003US20030061625 Modulation of PDE11A activity
03/27/2003US20030060602 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060601 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060600 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060444 In which an effector cell is transformed with DNA coding for chimeric receptor containing two or more cytoplasmic signalling components derived from tetraspan-transmembrane protein or antigens; anticancer agents
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060417 Novel gene having reverse transcriptase motif
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059921 Novel clot-specific steptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins
03/27/2003US20030059920 Sterilizing glycosidase preparation; obtain glycosidase preparation, irradiate, monitor glycosidase activity
03/27/2003US20030059919 Novel human 39228, 21956, 25856, 22244, 8701, 32263, 50250, 55158, 47765, 62088, 50566, and 48118 molecules and uses therefor
03/27/2003US20030059918 Regulation of human serine/threonine protein kinase
03/27/2003US20030059917 Mixture containing preferential polypeptide for use in treatment of tumors
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059915 Galactosyltransferase for use in the biosynthesis of extended O-linked glycans
03/27/2003US20030059914 Microorganismal culture for use in the generation of transglutaminases; for use in food processing and cosmetics
03/27/2003US20030059913 Novel Microorganisms with ability to degrade indole and novel enzymes therefrom
03/27/2003US20030059910 Oil bodies and associated proteins as affinity matrices
03/27/2003US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/27/2003US20030059908 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and cardiovascular disorders
03/27/2003US20030059904 Process for producing l-amino acids via fermentation method
03/27/2003US20030059902 Polypeptide for use in retarding aging of baked goods
03/27/2003US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059884 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059881 Polypeptide for use in the treatment of inflammatory, autoimmune and cancer diseases
03/27/2003US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders
03/27/2003US20030059872 Nucleotide sequences coding polypeptide for use as diagnostic tools in genetic engineering
03/27/2003US20030059870 Expression vector for use as gene transfer and modification tool in genetic engineering
03/27/2003US20030059864 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
03/27/2003US20030059854 Detecting modulators of enzyme activity; obtain sample containing preferential kinase, incubate with modulator, monitor adjustment in phosphorylation, adjustment in phosphorylation indicates modulator
03/27/2003US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059829 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059828 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059816 Methods for identifying racemases
03/27/2003US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof
03/27/2003US20030059800 Nucleotide sequences coding polypeptide for use in in vitro models for drug metabolism; for use in detection of toxins in environment
03/27/2003US20030059787 Detection of preferential nucleotide sequences coding telomerase; obtain sample containing nucleotide sequences, incubate with probe, detect hybridization product, presence of product indicates gene for telomerase
03/27/2003US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059775 Novel proteins and nucleic acids encoding same
03/27/2003US20030059772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059769 High affinity nucleic acid ligands to lectins
03/27/2003US20030059768 Novel polypeptides and nucleic acids encoding same
03/27/2003US20030059475 Fibrin microbeads and uses thereof
03/27/2003US20030059464 Delivering p21(protein) to hair follicles of a mammal by applying topically to skin areas of a mammal having multiple hair follicels, an effective amount of a nucleotide sequence encoding the p21 protein
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059441 Unmarked mutation is a mutated nucleotide sequence introduced into mycobacterium where sequence does not contain selectable marker such as gene conferring antibiotic resistance to recombinant mycobacterium incorporating mutated sequence
03/27/2003US20030059437 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059419 Identification of novel substrate I-TRAF of IKK-i kinase
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030058780 Disk device
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2461050A1 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes
03/27/2003CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003CA2460819A1 Methods and apparatuses for purification
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460546A1 Dna polymerases and mutants thereof
03/27/2003CA2460499A1 A gene encoding cyclododecanone monooxygenase
03/27/2003CA2460372A1 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459137A1 Receptors and membrane-associated proteins
03/27/2003CA2454319A1 Multi-site mutagenesis
03/27/2003CA2447583A1 Dsp-18 dual-specificity phosphatase
03/27/2003CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/26/2003EP1295946A1 Sulfate transferase and dna encoding this enzyme
03/26/2003EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
03/26/2003EP1295937A2 Candida boidinii formic hydrogenase mutants
03/26/2003EP1294942A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods
03/26/2003EP1294928A1 Screening method for modulators of suv39h2-methyltransferase
03/26/2003EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
03/26/2003EP1294925A2 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target
03/26/2003EP1294917A2 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells
03/26/2003EP1294916A2 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
03/26/2003EP1294913A1 Changing the fine chemical content in organisms by genetically modifying the shikimate pathway
03/26/2003EP1294912A2 Gtp binding stress-related proteins and methods of use in plants
03/26/2003EP1294910A2 Protein glycosylation modification in pichia pastoris
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294903A2 Regulation of human transmembrane serine protease
03/26/2003EP1294902A2 Treatment methods using 17906 and uses therefor
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294900A1 Nucleic acids coding for a plant phosphatase of the mipp type with phytase activity and uses
03/26/2003EP1294899A2 16836, a human phospholipase c family member and uses thereof
03/26/2003EP1294898A2 FATTY ACID ELONGASE 3-KETOACYL CoA SYNTHASE POLYPEPTIDES
03/26/2003EP1294897A2 21910, a membrane-associated guanylate kinase and uses thereof
03/26/2003EP1294896A2 13295 novel protein kinase molecules and uses therefor
03/26/2003EP1294895A2 Calpain protease 12
1 ... 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 ... 1416